FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Shareholders News

Most Popular Shareholders Story

Investors revolt to block Elan sale

Investors at Elan aren't going to take it anymore. They're stepping up to block the sale of a stake in the company to a "large pharmaceuticals partner," the Financial Times reports. And they're Read more...

Latest Headlines